title: [Treatment of resistant primary glomerulopathies].
abstract: Considerable progress in understanding of the pathogenesis of a number of primary glomerular diseases is evident. Scientific achievements in this field led to reclassification of certain types of glomerulonephritides, development of new diagnostic tests, as well as new therapeutic approaches. These new findings will enable us to treat primary glomerulopathies more efficiently thus reducing incidence of resistant disease. Novelties in diagnostics, treatment algorithm, characteristics of the resistant disease and the possibilities of specific treatment are shown in this review.
authors.forename: Mario
authors.initials: M
authors.lastname: Laganović
authors.forename: Ana
authors.initials: A
authors.lastname: Vrdoljak
authors.forename: Vedran
authors.initials: V
authors.lastname: Premuzić
authors.forename: Jelena
authors.initials: J
authors.lastname: Kos
authors.forename: Tajana Zeljković
authors.initials: TZ
authors.lastname: Vrkić
authors.forename: Zivka
authors.initials: Z
authors.lastname: Dika
authors.forename: Bojan
authors.initials: B
authors.lastname: Jelaković
mesh_terms: D003928:Diabetic Nephropathies / Q000175:diagnosis / Q000628:therapy; D003955:Diagnostic Tests, Routine; D005921:Glomerulonephritis / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D015432:Glomerulonephritis, Membranoproliferative / Q000175:diagnosis / Q000628:therapy; D015433:Glomerulonephritis, Membranous / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D015994:Incidence; D007678:Kidney Glomerulus / Q000473:pathology